Form 4: Mirum Pharmaceuticals SVP, Global Controller, Jolanda Howe, Reports Stock Transactions
SEC Form 4 Filing
Jolanda Howe, SVP, Global Controller of Mirum Pharmaceuticals, reports the acquisition and disposal of common stock and restricted stock units on July 1st and 2nd, 2024.
Summary
- On July 1, 2024, Jolanda Howe, SVP, Global Controller of Mirum Pharmaceuticals, acquired 1,042 shares of common stock through the vesting of restricted stock units.
- Also on July 1, 2024, Ms. Howe disposed of 2,801 shares of common stock.
- On July 2, 2024, Ms. Howe disposed of 375 shares of common stock at a price of $34 per share to cover tax withholding obligations.
- Following these transactions, Ms. Howe directly owns 2,426 shares of common stock and 1,041 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are standard disclosures required by the SEC for insiders of publicly traded companies, providing transparency into their transactions in the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a company insider.
Key Dates
| Date | Description |
|---|---|
| 07/01/2023 | Beginning date of the series of three successive equal annual installments for vesting of restricted stock units. |
| 07/01/2024 | Date of acquisition of 1,042 shares of common stock and disposal of 2,801 shares of common stock. |
| 07/02/2024 | Date of disposal of 375 shares of common stock at $34 per share. |
| 07/03/2024 | Date of signature of the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.